Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mannatech, Glycoproducts split decision

This article was originally published in The Tan Sheet

Executive Summary

A federal court jury rules in favor of Glycoproducts International regarding infringement of one Mannatech patent in its Glycomannan product, but found the Riggins, Idaho-based firm infringed on a second patent for Mannatech's Ambrotose glyconutrient supplement. The jury in the U.S. District Court for the Northern District of Texas affirmed Mannatech's claim that Glycoproducts infringed on its Ambrotose trademark, the firms say May 28. Coppell, Texas-based Mannatech will pursue an injunction prohibiting Glycoproducts from producing and selling Glycomannan, as well as the reimbursement of its legal fees. Glycoproducts will oppose the injunction request...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101770

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel